The curative effects of shortwave diathermy on treating Novel coronavirus (COVID-19) pneumonia: A structured summary of a study protocol for a randomised controlled trial
This study will be conducted in Tongji Hospital, Caidian, Wuhan, People ’s Republic of China.Intervention and comparatorThe experimental group will be given the nationally recommended standard medical treatment + ultra-short-wave diathermy treatment. Ultra-short-wave therapy treatment will be performed through application of ultra-short-wave therapy machine electrodes on the anterior and posterior parts of the trunk for 10 minutes, twice a day for 12 consecutive days. The comparator will be the control, not receiving ultra-short-wave therapy, and will be given only the nationally recommended standard medical treatmen...
Source: Trials - July 3, 2020 Category: Research Source Type: clinical trials

Immunization With BCG Vaccine to Prevent Tuberculosis Infection
Condition:   Tuberculosis Infection Interventions:   Biological: BCG (Tokyo 172) vaccine;   Drug: Placebo Sponsors:   Henry M. Jackson Foundation for the Advancement of Military Medicine;   United States Department of Defense;   Uniformed Services University of the Health Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2020 Category: Research Source Type: clinical trials

The Effect of Latent Tuberculosis Infection on the Pregnancy Outcome of IVF-ET
Conditions:   Infertility;   Tuberculosis Intervention:   Other: No intervention Sponsor:   Peking University Third Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2020 Category: Research Source Type: clinical trials

Delayed Diagnosis of Bacteriologically Positive Pulmonary Tuberculosis and Relative Optimized Suggestions in China
Condition:   Tuberculosis; Pulmonary, Confirmed, Unspecified Means Intervention:   Sponsor:   Huashan Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 17, 2020 Category: Research Source Type: clinical trials

Xpert MTB/RIF Test in the Diagnosis of Pulmonary Tuberculosis
Condition:   Pulmonary Tuberculosis Confirmation by Culture Intervention:   Diagnostic Test: Xpert MTB/RIF test Sponsors:   Taipei Medical University WanFang Hospital;   Buddhist Tzu Chi General Hospital;   Chest Hospital, Ministry of Health and Welfare, Taiwan;   Chang-Hua Hospital;   Taichung Veterans General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2020 Category: Research Source Type: clinical trials

Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation
Conditions:   Latent Tuberculosis;   Diabetes Mellitus, Type 2 Interventions:   Drug: Rifampicin 300 Mg Oral Capsule;   Drug: Isoniazid 300 MG Sponsor:   Herlev and Gentofte Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2020 Category: Research Source Type: clinical trials

Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)
AbstractObjectivesTo assess the safety and therapeutic effects of allogeneic human dental pulp stem cells (DPSCs) in treating severe pneumonia caused by COVID-19.Trial designThis is a single centre, two arm ratio 1:1, triple blinded, randomized, placebo-controlled, parallel group, clinical trial.ParticipantsTwenty serious COVID-19 cases will be enrolled in the trial from April 6th to December 31st 2020. Inclusion Criteria: hospitalised patients at Renmin Hospital of Wuhan University satisfy all criteria as below:Adults aged 18-65 years;Voluntarily participate in this clinical trial and sign the “informed consent form...
Source: Trials - June 12, 2020 Category: Research Source Type: clinical trials

Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation
Conditions:   Latent Tuberculosis;   Diabetes Mellitus, Type 2 Interventions:   Drug: Rifampicin 300 Mg Oral Capsule;   Drug: Isoniazid 300 MG Sponsor:   Herlev and Gentofte Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2020 Category: Research Source Type: clinical trials